These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21798088)

  • 1. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.
    Gawlik KI; Durbeej M
    Skelet Muscle; 2011 Mar; 1(1):9. PubMed ID: 21798088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
    Durbeej M
    Curr Top Membr; 2015; 76():31-60. PubMed ID: 26610911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
    Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
    J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.
    Van Ry PM; Minogue P; Hodges BL; Burkin DJ
    Hum Mol Genet; 2014 Jan; 23(2):383-96. PubMed ID: 24009313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
    Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
    Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
    Nguyen Q; Lim KRQ; Yokota T
    Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital muscular dystrophy type 1A with residual merosin expression.
    Kim HJ; Choi YC; Park HJ; Lee YM; Kim HD; Lee JS; Kang HC
    Korean J Pediatr; 2014 Mar; 57(3):149-52. PubMed ID: 24778697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of congenital muscular dystrophy and clinical significance of merosin expression].
    Xiong H; Yao S; Yuan Y; Chang XZ; Wu Y; Bao XH; Zhang YH; Wu HS; Chen L; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):918-23. PubMed ID: 17254461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.
    Domi T; Porrello E; Velardo D; Capotondo A; Biffi A; Tonlorenzi R; Amadio S; Ambrosi A; Miyagoe-Suzuki Y; Takeda S; Ruegg MA; Previtali SC
    Skelet Muscle; 2015; 5():30. PubMed ID: 26347253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
    Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
    Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
    J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma.
    Holmberg J; Alajbegovic A; Gawlik KI; Elowsson L; Durbeej M
    Front Aging Neurosci; 2014; 6():155. PubMed ID: 25071564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.
    Barraza-Flores P; Bates CR; Oliveira-Santos A; Burkin DJ
    Front Mol Neurosci; 2020; 13():1. PubMed ID: 32116540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity.
    Yoon S; Beermann ML; Yu B; Shao D; Bachschmid M; Miller JB
    J Neuromuscul Dis; 2018; 5(1):59-73. PubMed ID: 29278895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
    Vishnudas VK; Miller JB
    Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients.
    Kölbel H; Hathazi D; Jennings M; Horvath R; Roos A; Schara U
    Front Neurol; 2019; 10():470. PubMed ID: 31133972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin abnormalities in merosin-deficient congenital muscular dystrophy.
    Saito Y; Ishiyama A; Saito Y; Komaki H; Sasaki M
    Muscle Nerve; 2024 Jan; 69(1):55-63. PubMed ID: 37933889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.
    Yurchenco PD; McKee KK; Reinhard JR; Rüegg MA
    Matrix Biol; 2018 Oct; 71-72():174-187. PubMed ID: 29191403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.